Percheron Therapeutics Ltd
PER
Company Profile
Business description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Contact
14 Wallace Avenue
LEVEL 1
ToorakVIC3142
AUST: +61 398278999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
8
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,175.10 | 49.90 | 0.61% |
| CAC 40 | 7,532.96 | 30.18 | 0.40% |
| DAX 40 | 22,098.15 | 33.64 | 0.15% |
| Dow JONES (US) | 40,093.40 | 486.83 | 1.23% |
| FTSE 100 | 8,405.10 | 2.34 | -0.03% |
| HKSE | 21,976.84 | 67.08 | 0.31% |
| NASDAQ | 17,166.04 | 457.99 | 2.74% |
| Nikkei 225 | 35,705.74 | 666.59 | 1.90% |
| NZX 50 Index | 12,017.84 | 61.37 | 0.51% |
| S&P 500 | 5,484.77 | 108.91 | 2.03% |
| S&P/ASX 200 | 7,968.20 | 47.70 | 0.60% |
| SSE Composite Index | 3,295.06 | 2.23 | -0.07% |